have divided the plasmacytoma of the skull base into anterior nasopharyngeal group and central sphenoid, clivus, petrous apex group.. Moreover plasmacytomas are also classified as extram
Trang 1another six more cases since then.[1-6] Wein et al have
divided the plasmacytoma of the skull base into
anterior (nasopharyngeal) group and central (sphenoid,
clivus, petrous apex) group This is of prognostic
importance because in the central group, the rate of
progression to multiple myeloma is 63.6%, which is much
higher than that in the anterior group (9.5%) Moreover
plasmacytomas are also classified as extramedullary
plasmacytoma (EMP) or solitary plasmacytoma of
bone (SPB).[1] Most of the anterior group of skull base
plasmacytoma fall into EMP group and the central
skull base plasmacytoma fall into SPB group Since
solitary plasmacytoma represents only one end of the
spectrum of plasma cell tumors and represents a distinct
manifestation of a disease continuum, progression to
multiple myeloma is almost invariable Hence adjuvant
therapy is essential to arrest further progression of the
disease
This patient had involvement of frontal and ethmoidal
sinuses and eroding the floor of the anterior cranial fossa
and most probably falls into the group of EMP Hence,
though the tumor had been excised totally adjuvant
radiotherapy was given to the patient The possibility of
plasmacytoma has to be kept in mind in any osteolytic
tumor of the skull base
Acknowledgement
We thank Prof K Ramesh Rao, Department of Pathology,
Chettinad Superspeciality Hospital, Chennai, for providing
the histopathology pictures.
Ramesh Ganesan Vengalathur, Karthikeyan Veerasamy Kavindapadi, Balasubramanian Chandramouli
Department of Neurosurgery, Chettinad Superspeciality Hospital,
Chettinad Health City, Kelambakkam, Chennai, Tamil Nadu, India
E‑mail: drvgramesh@hotmail.com
References
1 Wein RO, Popat SR, Doerr TD, Dutcher PO Plasma cell tumors of the skull
base: Four case reports and literature review Skull Base 2002;12:77-86.
2 Ustuner Z, Basaran M, Kiris T, Bilgic B, Sencer S, Sakar B, et al Skull
base plasmacytoma in a patient with light chain myeloma Skull Base
2003;13:167-71.
3 Singh AD, Chacko AG, Chacko G, Rajshekhar V Plasma cell tumors
of the skull Surg Neurol 2005;64:434-8.
4 Pancholi A, Raniga S, Vohra PA, Vaidya V, Prajapati A, Mansingani S
Imaging features of extramedullary plasmacytoma of skull base
with multiple myeloma—A rare case Indian J Radiol Imaging
2006;16:29-32.
5 Yamaguchi S, Terasaka S, Ando S, Shinohara T, Iwasaki Y Neoadjuvant
therapy in a patient with clival plasmacytoma associated with multiple
myeloma: A case report Surg Neurol 2008;70:403-7.
6 Guinto-Balanzar G, Abdo-Toro M, Aréchiga-Ramos N, Leal-Ortega R,
Zepeda-Fernández E, Nambo-Lucio Mde J Plasma cell tumor of the
clivus: Report of two cases Cir Cir 2012;80:171-6.
Access this article online Quick Response Code: Website:
www.neurologyindia.com
PMID:
***
DOI:
10.4103/0028-3886.144457
Received: 16-07-2014 Review completed: 26-08-2014 Accepted: 03-10-2014
An unusually aggressive clinical behavior in a case of atypical subependymal giant cell astrocytoma
Sir, Subependymal giant cell astrocytoma (SEGA) is a benign tumor that mostly arises in the wall of the lateral ventricle.[1] Though it has been classified as a low grade, WHO Grade 1 tumor, aggressive lesions with metastasis and intratumoral hemorrhages have been described.[2,3]
High grade features like mitoses, focal necrosis, and endothelial proliferations are distinctly rare, but few cases have been reported in the literature with these unusual findings of high-grade tumor, termed as atypical SEGA.[4,5] Despite anaplasia in histology, the clinical behavior of these patients have been benign, same as typical SEGA A few cases of atypical SEGA may behave aggressively.[5] We report a case of atypical SEGA mimicking malignant glioma with an unusually aggressive clinical course
A 5-year-old male child presented with 1 month history
of worsening headache with right hemiparesis and facial weakness Magnetic resonance imaging (MRI) showed a large lesion in the left posterior thalamic region abutting the atrial wall with peripheral enhancement with edema [Figure 1a and b] There were no markers of tuberous sclerosis complex (TSC) The patient underwent
a parietooccipital craniotomy and near total resection
of the tumor through transcortical, transventricular route [Figure 1c and d] Immediate postoperative period was uneventful The histology showed spindle-shaped
to large polygonal tumor cells with many multinucleated giant cells scattered in between [Figure 2] Large necrotic areas were observed Few mitotic figures were identified with Ki-67 labelling index around 2-3% The tumor also showed glial fibrillary acidic protein (GFAP) positivity
The overall features were suggestive of SEGA with atypical features Within 3 weeks of primary surgery, the patient presented with altered sensorium and progressively worsening right hemiparesis MRI showed a small
Trang 2recurrent lesion with hydrocephalus Ventriculoperitoneal
shunt was placed following which the sensorium
improved In view of the early recurrence and high-grade
histological features, conformal radiotherapy was given
A month later, the clinical condition worsened and repeat
imaging showed increase in size of lesion with invasion of
adjacent structures [Figure 1e and f] Because of the poor
general condition, reexcision of tumor could not be offered
and the patient subsequently died within a fortnight
SEGAs are low-grade tumors that seem to arise from the
ependymal layer lining the ventricular walls They usually
arise near the foramen of Monro, though other ventricular
Figure 1: (a and b) Preoperative MRI showing large heterogeneous left thalamic lesion with peripheral contrast enhancement (c and d) Postoperative
CT showing near total excision of the tumor (e and f) Plain CT and contrast-enhanced MRI at 4 months showing large recurrence
MRI = Magnetic resonance imaging, CT = computed tomography
d
c b
f
a
e
Figure 2: (a) Low power photomicrograph showing a cellular tumor
with large areas of necrosis (H and E, ×4), (b) The tumor is composed
of bizarre, multinucleated cells in a fibrillary background (H and E, ×20)
(c) Tumor cells show strong GFAP expression (IP, ×20) (d) Ki-67
immunostain showing high proliferative index in tumor cells (IP, ×40)
H and E = Hematoxylin and Eosin, IP = Immunoperoxidase
d c
b a
locations have been described It has been linked with TSC, though occasionally, they can occur sporadically.[1] It most frequently occurs in the first 2 decades of life Owing
to its periventricluar location they frequently obstruct the ventricular pathway producing symptoms of raised pressure with other clinical manifestations being seizure, mental retardation, cognitive disability, and visual disturbances Computed tomography (CT) shows uniformly dense lesion with occasional peripheral calcifications These are commonly homogenous lesions with occasional cystic changes that appear isohypointese on T1-weighted (T1W) and hyperintense on T2W images with marked contrast enhancement Histologically it is composed of three types
of cells: Swollen gemistocytic cells, fibrillated spindle cells, and giant ganglion-like cells.[1] There are large polygonal cells with abundant cytoplasm arranged in sheets, clusters,
or pseudorosettes with different degrees of vascularization, angiocentric pattern, and calcifications Few cases may show anaplastic features like nuclear pleomorphism, mitosis, necrosis, microvascular proliferation, and increased Ki-67 index; but traditionally these high-grade features have been said not to impact the diagnosis or prognosis.[4]
These high-grade histologic features may easily lead to misdiagnosis of glioblastoma Absence of atypical small cells, low mitotic count, and Ki 67 index as compared
to glioblastoma have been suggested to be the best discriminative features.[4] In spite of presence of necrosis and mitosis, the biological behavior of these atypical tumors
is not aggressive and does not mandate radiotherapy and chemotherapy However, cases of atypical SEGA have been described in young children with a more rapid growth pattern due to malignant change and hemorrhage.[4,5]
Trang 3In our case the tumor recurred very rapidly and
the clinical course was almost similar to malignant
tumors In contrast to the traditional belief, our patient
showed concordance between high-grade histological
features and the clinical outcome So it is difficult to
prognosticate these atypical SEGAs and the clinical
course may vary in different cases Utmost caution
should be exercised in managing these patients Those
with aggressive course should probably be treated as
other malignant gliomas
Devi Prasad Patra, Pravin Salunke, Debajyoti Chatterjee 1 , R K Vasishta 1
Departments of Neurosurgery, and 1 Histopathology, Post Graduate
Institute of Medical Education and Research, Chandigarh, India
E‑mail: drpravin_salunke@yahoo.co.uk
References
1 Ouyang T, Zhang N, Benjamin T, Wang L, Jiao J, Zhao Y, et al
Subependymal giant cell astrocytoma: Current concepts, management,
and future directions Childs Nerv Syst 2014;30:561-70.
2 Telfeian AE, Judkins A, Younkin D, Pollock AN, Crino P Subependymal
giant cell astrocytoma with cranial and spinal metastases in a patient
with tuberous sclerosis Case report J Neurosurg 2004;100 (5 Suppl
Pediatrics):498-500.
3 Ogiwara H, Morota N Subependymal giant cell astrocytoma with
intratumoral hemorrhage J Neurosurg Pediatr 2013;11:469-72.
4 Svajdler M Jr, Deák L, Rychlý B, Talarčík P, Fröhlichová L
Subependymal giant cell astrocytoma with atypical clinical and
pathological features: A diagnostic pitfall Cesk Patol 2013;49:76-9.
5 Grajkowska W, Kotulska K, Jurkiewicz E, Roszkowski M, Daszkiewicz P,
Jóźwiak S, et al Subependymal giant cell astrocytomas with atypical
histological features mimicking malignant gliomas Folia Neuropathol
2011;49:39-46.
Access this article online Quick Response Code: Website:
www.neurologyindia.com
PMID:
***
DOI:
10.4103/0028-3886.144458
Received: 13-10-2014 Review completed: 14-10-2014 Accepted: 15-10-2014
nerves Schwannomas arising from the oculomotor nerve are very rare, except with neurofibromatosis
Approximately 40 cases of oculomotor nerve schwannomas have been described in the literature, of which 12 cases were large (≥2.5cm)[1,2] tumors This report presents a case
of giant oculomotor nerve schwannoma
A 24-year-old female complained of progressive diplopia, ptosis of left eye for 2 years These complaints were overlooked by family members For the last six months, she had developed gradual progressive visual loss of left eye followed by right eye She also used
to have generalized headache, vomiting and features suggesting hypo-function of pituitary gland On examination, her visual acuity was figure counting at
1 meter distance in both the eyes with left oculomotor nerve palsy and bilateral optic atrophy Magnetic resonance imaging (MRI) of brain revealed a large,
enhancing mass (6.1 × 3.6 × 6.2 cm) with central necrosis
involving sellar and suprasellar regions, extending into left middle cranial fossa [Figures 1 and 2] Left pterional craniotomy and wide splitting of the Sylvian fissure for tumor access was carried out A large encapsulated, white, firm, moderately vascular, multilobulated tumor was found with a necrotic yellowish central zone Intratumoural decompression, followed by dissection of tumor in arachnoid plane carried out
Though the tumor was abutting internal carotid artery
Giant oculomotor nerve
schwannoma presenting as a
sellar and suprasellar mass
with parasellar extension
Sir,
Schwannomas account for 7% of all intracranial tumors and
commonly arise from the vestibulocochlear and trigeminal
Figure 1: An axial T1- and T2-weighted MRI scan showing (T1-hypointense and T2-hyperintense) sellar mass with left parasellar extension
Figure 2: Coronal and sagittal gadolinium-enhanced contrast T1-weighted MRI scan showing the said enhancing mass with central area
of hypointensity The lesion was compressing the optic chiasma with
ipsilateral carotid encasement
Trang 4email articles for individual use.